Skip to main content
. 2017 Aug 23;190(2):208–216. doi: 10.1111/cei.13009

Figure 2.

Figure 2

Interleukin (IL)‐4, transforming growth factor (TGF)‐β, thymic stromal lymphopoietin (TSLP), IL‐25, IL‐17RB and tumour necrosis factor (TNF) receptor associated factor 6 (TRAF6) expression in systemic sclerosis (SSc) and healthy donors (HD). IL‐4, TGF‐β, TSLP, IL‐25, IL‐17RB and TRAF6 expression in the skin of SSc patients (b,e,h,m,p,s) and controls (a,d,g,l,o,r). Quantification of IL‐4‐, TGF‐β–, TSLP‐, IL‐25‐, IL‐17RB‐ and TRAF6‐producing cells from SSc patients and controls (c,f,i,n,q,t). Original magnification ×250. Data are expressed as mean ± standard error of the mean (s.e.m.); *P < 0·05. [Colour figure can be viewed at wileyonlinelibrary.com]